Benefits and risks of increasing restrictions on access to costly drugs in Medicaid.

@article{Soumerai2004BenefitsAR,
  title={Benefits and risks of increasing restrictions on access to costly drugs in Medicaid.},
  author={Stephen B. Soumerai},
  journal={Health affairs},
  year={2004},
  volume={23 1},
  pages={
          135-46
        }
}
States are reacting to increased Medicaid drug costs by implementing cost-control policies, such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as benefits. Targeting essential drug classes with heterogeneous patient responses and side effects could reduce appropriate care, adversely affect health status, and cause shifts to more costly types of care. Assessing inappropriate use of high-cost drugs before implementing regulations and instituting simple mechanisms… CONTINUE READING
Highly Cited
This paper has 84 citations. REVIEW CITATIONS
Tweets
This paper has been referenced on Twitter 5 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 51 citations

85 Citations

051015'06'09'12'15'18
Citations per Year
Semantic Scholar estimates that this publication has 85 citations based on the available data.

See our FAQ for additional information.